A small study of glucagon-like peptide 2 (GLP-2) drug as a treatment for steroid-refractory acute graft-versus-host disease (GVHD) yielded promising...
shows
Pharma major Novartis on Saturday announced that its drug Lutathera has shown significantly improved patient outcomes for gastroenteropancreatic neuroendocrine tumors....
